Shortage outlook · by company · read 11 November 2026

Which drugs does SpecGx LLC have on the FDA shortage list?

SpecGx LLC has 13 presentations of 2 drugs on the FDA shortage list, 0 of them reported unavailable. Each is the company's own report to the FDA, with the date of its last update. A report is the company's statement, not a check of any pharmacy's stock.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.

SpecGx LLCcompany reports to the FDA shortage list

2drugs on the list

SpecGx LLC has 13 presentations of 2 drugs on the FDA shortage list in 11 November 2026.

The company reported 10 available, 3 with limited availability and 0 unavailable.

Drug by drug, as the company reported it

Lisdexamfetamine (Vyvanse generics)7 presentations · on the list 3 years and 3 months · last updated 20 August 2026
Mixed amphetamine salts (Adderall generics)6 presentations · on the list 4 years · last updated 20 August 2026

FDA current shortage listing file, read 11 November 2026. Availability is the company's own statement to the FDA, not a check of any pharmacy's stock.

Where can you go from here?

Look up any medicine to see how long it has been listed and every company that reports it. The FDA explains what a listing means in the FDA's frequently asked questions about drug shortages, and the list itself is the FDA drug shortages database.